We are live on ! Find out more
CCC

Crescent Capital Consulting Portfolio holdings

AUM $607M
1-Year Est. Return 22.88%
This Fund
S&P 500
This Quarter Est. Return
+8.85%
1 Year Est. Return
+22.88%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$607M
AUM Growth
+$61.5M
Cap. Flow
+$14.9M
Cap. Flow %
2.45%
Top 10 Hldgs %
39.81%
Holding
643
New
50
Increased
104
Reduced
60
Closed
115

Sector Composition

Rank Sector Weight
1 Technology 5.49%
2 Healthcare 4.4%
3 Consumer Staples 3.49%
4 Materials 3.38%
5 Financials 2.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WY icon
401
Weyerhaeuser
WY
$17.3B
$8K ﹤0.01%
200
ZBH icon
402
Zimmer Biomet
ZBH
$17.4B
$8K ﹤0.01%
62
HEP
403
DELISTED
Holly Energy Partners, L.P.
HEP
$8K ﹤0.01%
500
BBY icon
404
Best Buy
BBY
$17.9B
$7K ﹤0.01%
66
CCL icon
405
Carnival Corporation Ltd
CCL
$35.7B
$7K ﹤0.01%
354
CLX icon
406
Clorox
CLX
$11.6B
$7K ﹤0.01%
42
STEW
407
SRH Total Return Fund
STEW
$1.76B
$7K ﹤0.01%
500
VEEV icon
408
Veeva Systems
VEEV
$32.1B
$7K ﹤0.01%
26
CTSH icon
409
Cognizant
CTSH
$21.1B
$6K ﹤0.01%
63
DECK icon
410
Deckers Outdoor
DECK
$14.4B
$6K ﹤0.01%
96
EBAY icon
411
eBay
EBAY
$50.7B
$6K ﹤0.01%
92
NKE icon
412
Nike
NKE
$64.5B
$6K ﹤0.01%
38
OSK icon
413
Oshkosh
OSK
$8.85B
$6K ﹤0.01%
52
SPG icon
414
Simon Property Group
SPG
$74B
$6K ﹤0.01%
40
SYF icon
415
Synchrony
SYF
$24.7B
$6K ﹤0.01%
136
VMEO
416
DELISTED
Vimeo
VMEO
$6K ﹤0.01%
313
BERY
417
DELISTED
Berry Global Group, Inc.
BERY
$6K ﹤0.01%
85
CDK
418
DELISTED
CDK Global, Inc.
CDK
$6K ﹤0.01%
160
BIO icon
419
Bio-Rad Laboratories Class A
BIO
$8.08B
$5K ﹤0.01%
6
DVA icon
420
DaVita
DVA
$15B
$5K ﹤0.01%
44
IPG
421
DELISTED
Interpublic Group of Companies
IPG
$5K ﹤0.01%
135
JBL icon
422
Jabil
JBL
$32.1B
$5K ﹤0.01%
67
PHM icon
423
Pultegroup
PHM
$23.5B
$5K ﹤0.01%
86
RIVN icon
424
Rivian
RIVN
$25B
$5K ﹤0.01%
+50
New +$5.76K
TRIP icon
425
TripAdvisor
TRIP
$1.68B
$5K ﹤0.01%
193

Similar funds

Crescent Capital Consulting's Q4 2021 Portfolio in Review

As of Q4 2021, Crescent Capital Consulting held 643 positions worth $607M, up 11% from $546M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Crescent Capital Consulting's Q4 2021 filing shows 50 new, 104 increased, 60 reduced and 115 closed positions. Its largest new stake was Invesco BulletShares 2024 High Yield Corporate Bond ETF: 454,682 shares worth $11.4M. The largest sale was iShares MSCI ACWI ex US ETF, an estimated $8.26M.

By sector, the portfolio is most concentrated in Technology at 5.5% of assets, up from 4.9% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Crescent Capital Consulting's largest Q4 2021 buy was Invesco BulletShares 2024 High Yield Corporate Bond ETF: 454,682 shares worth $11.4M.
  • Crescent Capital Consulting added most to iShares TIPS Bond ETF in Q4 2021, an estimated $12.1M increase.
  • Crescent Capital Consulting's biggest Q4 2021 reduction was iShares MSCI ACWI ex US ETF, cutting an estimated $8.26M.
  • Crescent Capital Consulting fully exited iShares iBonds 2023 Term High Yield and Income ETF in Q4 2021, selling an estimated $297K.
  • Crescent Capital Consulting's ten largest holdings make up 40% of its $607M portfolio in Q4 2021.
  • Crescent Capital Consulting opened 50 new positions and closed 115 in Q4 2021.
  • Crescent Capital Consulting's portfolio value rose 11% quarter-over-quarter to $607M.

Based on Crescent Capital Consulting's 13F filing for Q4 2021, filed 18 Jan 2022.